SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending amid strong community enthusiasm for its new WolfSWAP, a cross-chain aggregator offering utility and fee-sharing across over 20 networks. The "Wolfpack" believes this focus on decentralization and innovation, with a significant flagship utility planned for 2026, sets SAILANA apart as a memecoin building long-term value and garnering "early $SHIB vibes" from believers.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT is trending amidst a surge in trading volume and recent listings on major exchanges, boosted by its "Glacier Drop" airdrop. The community is buzzing about its vision as a privacy-focused blockchain within the Cardano ecosystem, aiming for institutional adoption with compliant ZK technology and developer-friendly tools. Discussions highlight its unique 'rational privacy' approach and notable price movements as it gains visibility.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is at the center of a highly polarized community discussion, with significant frustration over its sustained market performance leading to strong FUD and accusations against its founder. Conversely, its native meme coin ecosystem, featuring projects like $COCK and $NIGHT, continues to launch new dApps and establish partnerships, creating a counter-narrative of ecosystem growth. The cryptocurrency is also being actively compared to newer Layer 1 infrastructures like Keeta ($KTA), which proponents highlight for its high-throughput and compliance-focused design for institutional finance.

Snek is a cultural movement and leading currency for meme creators worldwide.

SNEK

SNEK is trending due to its expanding utility and strategic partnerships within the Cardano ecosystem, with recent major exchange listings increasing its visibility. The community is actively discussing its real-world asset integration through the Cocky Wings partnership selling Snek Energy drinks, highlighting its role as a key liquidity bridge for Cardano assets.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network (ZBCN) is actively trending as the community highlights its recent ISO 20022 compliance and expanding partnerships with key financial institutions like Nacha and NatPay, positioning it for future utility in real-time payments. While discussions include anticipation for its Super App and the distinction of its Coinbase tradability, many investors view current price levels as a significant accumulation phase for a potentially transformative long-term crypto asset.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as recent news highlights its expanded pipeline with new anticoagulant assets and progress on Tecarfarin's manufacturing, further bolstered by a collaboration for its pivotal Phase 3 trial. While bullish investors point to the low float and regulatory designations as indicators of significant upside, the community remains polarized with strong bearish sentiment focused on ongoing dilution concerns and the company's financial needs.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending after its QPerfect division launched a GPU-accelerated quantum emulator with NVIDIA CUDA-Q compatibility, significantly advancing its technological capabilities. This integration has sparked community excitement, positioning BTQ as a critical player in developing post-quantum cryptography for digital assets and financial systems against emerging quantum threats. While enthusiasm builds for potential widespread adoption, the market remains keenly focused on future revenue generation.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following recent successful asset-backed securitization deals, which reinforce demand for its AI-driven lending platform. The community is sharply divided, with bulls highlighting the company's strong fundamentals and profitability as indicators of significant growth potential, while skeptics vocalize concerns over insider selling, perceived stock manipulation, and market sentiment regarding consumer loan quality. This divergence creates intense debate around the company's valuation, especially as it navigates the broader macroeconomic landscape.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals (SPRY) is trending due to accelerating adoption of its Neffy nasal spray, supported by robust revenue growth and expanding global approvals across Europe and Asia. Community discussion highlights both significant short squeeze potential and intense debate over Neffy's market share against competitors, including a citizen petition filed by SPRY. The company's non-dilutive funding and pursuit of new indications like hives treatment further underscore its strategy to disrupt the allergy care market.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

FOX CRYPTO is generating buzz amidst extreme community sentiment, with many anticipating an imminent technical breakout from a multi-year downtrend. While some express frustration over its past performance, a strong contingent believes the token is fundamentally undervalued, touting its DeFi utility as comparable to larger platforms like Uniswap, and predicting a significant rally during the upcoming altcoin season.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

📈⚠️ Stocks with Recent Surge in Short Interest ⚠️📈 
 
$BINI $AMZD $MSFD $ORIS $SGD

Trading

moemen farouk

Zappy Zapp Zapp

Linda

$BINI $AMZD $MSFD $ORIS $SGD  
 
Hi Paul, 
 
Your figures for BINI are wrong. 
 
In their Pre14A filing on August 19th, BINI reported about 7.5 million outstanding shares. 
 
The latest short share report would be for the end of July, but BINI had a 250 to 1 reverse split on Aug 4th. 
 
That reported number of short shares would  have been based on the number of short shares when there were about 450 million shares of BINI.  Meanwhile, your divisor was most likely the out-of-date outstanding share count that you reported. 
 
So you are reporting figures which give a nonsensical short interest number for BINI.  To get realistic figures, you could either adjust the number of short shares by dividing them by 250, or you could simply not report the number at all.  I&#39;m not sure if your process is fully automated or not, but if it is fully automated, you should have a sanity check step which causes you to have to manually review it for figures so out of line with reality.